Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 BALANCE trial.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/predictive-biomarker-guides-prostate-cancer-hormone-therapy-2025a1000qdo?src=rss
Author :
Publish date : 2025-10-01 14:55:00
Copyright for syndicated content belongs to the linked Source.